Month: February 2025

Retrieve Medical, Inc. Emphasizes Proactive Compliance Amidst Upcoding Scrutiny: Our Patent Pending Preprocessor has Multi-billion Dollar Market Potential

BEDMINSTER, N.J., Feb. 28, 2025 /PRNewswire/ -- In light of recent reports regarding investigations into Medicare Advantage billing practices, Retrieve...

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS...

error: Content is protected !!